RAP Offers HIV-Associated Malignancies Research Funding Opportunity
AIDS-defining and non-AIDS defining malignancies are emerging as a major source of morbidity and mortality among HIV-positive men and women.
The Resource Allocation Program (RAP) is providing this funding opportunity to stimulate research on HIV-associated malignancies and to foster multidisciplinary collaborations between the UCSF-Gladstone Institute of Virology and Immunology Center for AIDS Research (CFAR) investigators and the UCSF Helen Diller Family Comprehensive Cancer Center members by supporting one-year pilot research projects in HIV-associated malignancies.
The application deadline is Friday, Jan. 8, 2010. Results of this competition will be available in January 2010.
Each project will be required to have a CFAR member, and a cancer center co-investigator.
Pilot studies may be funded to a maximum of $75,000, and may include the following:
- Basic research
- Translational and clinical research on the etiology
- Pathogenesis
- Prevention and management of AIDS-defining and non-AIDS defining malignancies.
This is a special off-cycle RAP funding opportunity, and these applications are only accepted online through the RAP website.